大地國際集團(08130.HK):委任康錦裏為公司祕書、授權代表及法律程序代理人
格隆匯3月7日丨大地國際集團(08130.HK)此宣佈,麥寶文已於公吿日期提交辭呈辭任(i)公司的聯席公司祕書("聯席公司祕書");(ii)根據聯交所GEM證券上市規則第5.24條所規定的公司的授權代表("授權代表");及(iii)根據GEM上市規則第24.05(2)條及《公司條例》(香港法例第622章)第16部所規定的代公司在香港接受送達的法律程序文件及通知書的公司的授權代表("法律程序代理人"),均自2022年3月5日起生效。
緊隨麥寶文和陳勇不再擔任聯席公司祕書後,康錦裏獲委任為公司的公司祕書、授權代表及法律程序代理人,自2022年3月5日起生效。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.